Tönges, Lars

Guidelines for the use and interpretation of assays for monitoring autophagy

Klionsky, D. J., Abdalla, F. C., Abeliovich, H., Abraham, R. T., Acevedo-Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre-Ghiso, J. A., et al. (2012) · Autophagy

Autophagy in Disease and TherapyCalcium signaling and nucleotide metabolism

Cited by 3,996

Mechanisms of acute axonal degeneration in the optic nerve in vivo

Knöferle, J., Koch, J. C., Ostendorf, T., Michel, U., Planchamp, V., Vutova, P., Tönges, L., Stadelmann, C., Brück, W., Bähr, M., et al. (2010) · Proceedings of the National Academy of Sciences

Nerve injury and regenerationAutophagy in Disease and Therapy

Cited by 310

ROCK inhibition in models of neurodegeneration and its potential for clinical translation

Koch, J. C., Tatenhorst, L., Roser, A.-E., Saal, K.-A., Tönges, L., & Lingor, P. (2018) · Pharmacology & Therapeutics

Protein Kinase Regulation and GTPase SignalingAlzheimer's disease research and treatments

Cited by 239

ROCK2 is a major regulator of axonal degeneration, neuronal death and axonal regeneration in the CNS

Koch, J. C., Tönges, L., Barski, E., Michel, U., Bähr, M., & Lingor, P. (2014) · Cell Death & Disease

Nerve injury and regenerationAxon Guidance and Neuronal Signaling

Cited by 197

Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease

Tatenhorst, L., Eckermann, K., Dambeck, V., Fonseca-Ornelas, L., Walle, H., Lopes da Fonseca, T., Koch, J. C., Becker, S., Tönges, L., Bähr, M., et al. (2016) · Acta Neuropathologica Communications

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 158

Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosis

Tönges, L., Günther, R., Suhr, M., Jansen, J., Balck, A., Saal, K., Barski, E., Nientied, T., Götz, A. A., Koch, J., et al. (2014) · Glia

Amyotrophic Lateral Sclerosis ResearchNeuroinflammation and Neurodegeneration Mechanisms

Cited by 121

Axonal degeneration as a therapeutic target in the CNS

Lingor, P., Koch, J. C., Tönges, L., & Bähr, M. (2012) · Cell and Tissue Research

Nerve injury and regenerationHereditary Neurological Disorders

Cited by 119

Interventional Influence of the Intestinal Microbiome Through Dietary Intervention and Bowel Cleansing Might Improve Motor Symptoms in Parkinson’s Disease

Hegelmaier, T., Lebbing, M., Duscha, A., Tomaske, L., Tönges, L., Holm, J. B., Bjørn Nielsen, H., Gatermann, S. G., Przuntek, H., & Haghikia, A. (2020) · Cells

Parkinson's Disease Mechanisms and TreatmentsGut microbiota and health

Cited by 118

Modulation of Microglial Activity by Rho-Kinase (ROCK) Inhibition as Therapeutic Strategy in Parkinson’s Disease and Amyotrophic Lateral Sclerosis

Roser, A.-E., Tönges, L., & Lingor, P. (2017) · Frontiers in Aging Neuroscience

Neuroinflammation and Neurodegeneration MechanismsParkinson's Disease Mechanisms and Treatments

Cited by 77

Emerging Immunotherapies for Parkinson Disease

Zella, S. M. A., Metzdorf, J., Ciftci, E., Ostendorf, F., Muhlack, S., Gold, R., & Tönges, L. (2019) · Neurology and Therapy

Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 64

TGF-β 1 enhances neurite outgrowth via regulation of proteasome function and EFABP

Knöferle, J., Ramljak, S., Koch, J. C., Tönges, L., Asif, A. R., Michel, U., Wouters, F. S., Heermann, S., Krieglstein, K., Zerr, I., et al. (2010) · Neurobiology of Disease

Ubiquitin and proteasome pathwaysParkinson's Disease Mechanisms and Treatments

Cited by 50

Rho Kinase Inhibition with Fasudil in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis—Symptomatic Treatment Potential after Disease Onset

Günther, R., Balck, A., Koch, J. C., Nientiedt, T., Sereda, M., Bähr, M., Lingor, P., & Tönges, L. (2017) · Frontiers in Pharmacology

Amyotrophic Lateral Sclerosis ResearchNeurogenetic and Muscular Disorders Research

Cited by 47

Propionic acid and fasudil as treatment against rotenone toxicity in an in vitro model of Parkinson's disease

Ostendorf, F., Metzdorf, J., Gold, R., Haghikia, A., & Tönges, L. (2020) · Molecules

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 46